Graves病甲状腺功能亢进通过交感神经过度紧张导致睡眠障碍
研究纳入72名参与者(22例新诊断未治疗Graves病甲亢、20例既往诊断甲功正常Graves病、30名正常对照),比较组间匹兹堡睡眠质量指数(PSQI),并对新诊断组治疗12个月后前瞻观察。结果示未治疗甲亢组PSQI全局及睡眠紊乱评分最高,游离甲状腺素水平与PSQI全局评分独立相关,甲功正常化后睡眠评分显著改善。
要点
- 未治疗Graves病甲亢患者PSQI全局睡眠质量评分和睡眠紊乱评分在三组中最高。
- 游离甲状腺素水平与较差的PSQI全局睡眠质量评分独立相关(P = .006)。
- 甲功正常化及交感张力减弱后,PSQI全局评分(P = .018)和睡眠紊乱评分(P = .011)显著改善。
核心结论
- Graves病所致甲亢增强交感张力并加重主观睡眠障碍,甲功正常化可改善主观睡眠障碍。
研究设计与样本
- 2017年11月至2020年10月纳入72名无其他睡眠障碍相关基础疾病的参与者:22例新诊断未治疗甲亢的Graves病患者、20例既往诊断甲功正常的Graves病患者、30名正常对照。
- 比较各组入组时指标,并对新诊断Graves病患者治疗12个月后进行前瞻性观察。
主要发现
- PSQI全局睡眠质量评分(P = .036)和睡眠紊乱评分(P = .011)在三组间有显著差异,且均在未治疗甲亢组最高。
- 多因素回归分析显示,游离甲状腺素水平与较差的PSQI全局睡眠质量评分独立相关(P = .006),游离甲状腺素水平与以脉率评估的交感张力及尿总甲氧基肾上腺素呈正相关。
- 前瞻观察显示,随着甲功正常化和交感张力减弱,PSQI全局睡眠质量评分(P = .018)和睡眠紊乱评分(P = .011)显著改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: It is well known that Graves disease (GD) causes sleep disorders (SDs). However, the characteristics and associated factors of SD and its clinical course post hyperthyroidism normalization remain unclear. OBJECTIVE: To clarify the characteristics and associated factors of subjective SD and its clinical course after GD treatment. METHODS: From November 2017 to October 2020, we enrolled 72 participants (22 newly diagnosed with GD with untreated hyperthyroidism, 20 previously diagnosed with GD with normal thyroid function, and 30 normal controls) with no other underlying SD-related diseases. We compared the groups at enrollment and conducted prospective observations after 12 months of treatment on participants with newly diagnosed GD. Main outcome measures were differences and changes in the Pittsburgh Sleep Quality Index (PSQI) global and component sleep quality scores. RESULTS: PSQI global sleep quality scores (P = .036) and sleep disturbance scores (P = .011) were significantly different among the 3 groups, and were highest in the untreated hyperthyroidism group. Multiple regression analysis demonstrated that free thyroxine level, which was positively correlated with sympathetic tone (ST) as evaluated by pulse rate, and urinary total metanephrines was associated with poorer PSQI global sleep quality scores independently of other factors (P = .006). Prospective observation showed that PSQI global sleep quality scores (P = .018) and sleep disturbance scores (P = .011) significantly improved with thyroid function normalization and ST attenuation. CONCLUSION: Hyperthyroidism caused by GD augmented ST and exacerbated subjective SD. Normalization of hyperthyroidism caused by GD improved subjective SD.
引用
- Matsumoto K, Izawa S, Fukaya K, et al. Hyperthyroidism in Graves Disease Causes Sleep Disorders Related to Sympathetic Hypertonia. J Clin Endocrinol Metab. 2022. PMID: 35022743. doi:10.1210/clinem/dgac013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。